Increased hepatocyte growth factor level in cerebrospinal fluid in Alzheimer's disease. - Wikidata - wikimedia - TriplyDB

Increased hepatocyte growth factor level in cerebrospinal fluid in Alzheimer's disease.

Increased hepatocyte growth factor level in cerebrospinal fluid in Alzheimer's disease.

http://www.wikidata.org/entity/Q30768542

about

Novel CSF biomarkers for Alzheimer's disease and mild cognitive impairment CSF and Brain Indices of Insulin Resistance, Oxidative Stress and Neuro-Inflammation in Early versus Late Alzheimer's Disease Decreased Serum Hepatocyte Growth Factor (HGF) in Individuals with Depression Correlates with Severity of Disease Epitope Fingerprinting for Recognition of the Polyclonal Serum Autoantibodies of Alzheimer's Disease.Hepatocyte growth factor in cerebrospinal fluid differentiates community-acquired or nosocomial septic meningitis from other causes of pleocytosis Identifying amyloid pathology-related cerebrospinal fluid biomarkers for Alzheimer's disease in a multicohort study.Importance of the brain Angiotensin system in Parkinson's disease Decreased Serum Hepatocyte Growth Factor (HGF) in Individuals with Anxiety Increases After Zinc Therapy.The brain renin-angiotensin system: a diversity of functions and implications for CNS diseases.Human umbilical cord mesenchymal stem cells infected with adenovirus expressing HGF promote regeneration of damaged neuron cells in a Parkinson's disease model.Decreased Serum Hepatocyte Growth Factor (HGF) in Individuals with Bipolar Disorder Normalizes after Zinc and Anti-oxidant Therapy.Serum Hepatocyte Growth Factor Is Associated with Small Vessel Disease in Alzheimer's Dementia.Anxiolytic effect of hepatocyte growth factor infused into rat brain.

P2860

Q33894316-6C9B8501-ECB4-4FEE-A571-2B8450B7E5BB Q33896118-802352B8-1A7F-41AC-BF6D-50C92987DD1F Q34052678-674D0F19-EB8D-4899-85C8-ACEDB07279C4 Q35791399-27CBCC52-B545-45EE-A42F-604BD0BF58FB Q36092775-31E81681-63F7-4985-B855-2038B0204D2C Q36353787-72B96198-6F49-43FD-B2EB-7851E0DC2DE7 Q36415423-6BEBFD67-3D3F-4371-B7C8-2E1CD4C989F3 Q37078910-95ED141D-8D93-4CC0-86E0-77F9A16E143E Q38005611-8B1F0B7D-6C4F-4A52-8B0C-6C2697B3AA9D Q41718628-618918D4-854D-419C-B1DC-8CE70903DA6D Q42126586-7AB9982F-C11A-4CE6-A423-58F3B40F8EF3 Q49217407-C52AB687-4AC3-45BC-92AA-557D3F74B29E Q50982738-6235B72F-C714-4DEC-9657-BD4B3AFCA688

P2860

Increased hepatocyte growth factor level in cerebrospinal fluid in Alzheimer's disease.

http://www.wikidata.org/entity/Q30768542

description

2003 nî lūn-bûn

@nan

2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

name

Increased hepatocyte growth factor level in cerebrospinal fluid in Alzheimer's disease.

@ast

Increased hepatocyte growth factor level in cerebrospinal fluid in Alzheimer's disease.

@en

type

label

Increased hepatocyte growth factor level in cerebrospinal fluid in Alzheimer's disease.

@ast

Increased hepatocyte growth factor level in cerebrospinal fluid in Alzheimer's disease.

@en

prefLabel

Increased hepatocyte growth factor level in cerebrospinal fluid in Alzheimer's disease.

@ast

Increased hepatocyte growth factor level in cerebrospinal fluid in Alzheimer's disease.

@en

P1433

Q30768542-A2402095-C2C4-4AB3-8096-4ED52BC2457B

P1476

Q30768542-A41CBD72-94C3-4B93-8F30-EC332A018EE6

P2093

Q30768542-01F9AEF8-2930-48A0-B3B8-61C194F3ACC7

Q30768542-20FEB00A-2F65-4DF8-8F66-D6E565235D03

Q30768542-4F9E4F77-F7D8-40BC-868C-5BA9F791B13F

Q30768542-7030E631-A188-4DB4-A4D1-F9CAE0FC5F11

Q30768542-75BEAD7E-C994-47BD-AF31-B7A4DCFC0D42

Q30768542-A469DAF4-E186-40BC-B023-6FA75EA17B2B

Q30768542-B5854943-175E-4D4C-8B4E-7EE22DFF9B63

Q30768542-C524A630-4343-4AE1-835D-9F7D3589F162

Q30768542-F0254E0C-D851-488B-923B-2AB063B4BFEE

P2860

Q30768542-0926D8C1-3D06-475F-B529-73A78DE17D0C

Q30768542-19202159-23DB-471F-BD77-9989A9C0CA2B

Q30768542-3082B128-1798-43EC-8646-A0CEA8980A31

Q30768542-3B6A29D4-3452-46C9-A58E-BD6D67EDB5BA

Q30768542-3F192B40-27C0-45DC-A14A-78438702FC8F

Q30768542-5C071A66-E20E-4AFD-9822-1F3166178553

Q30768542-64AB7FDB-966E-44AD-9101-B3F89101E2A6

Q30768542-7BDDABC1-C14D-4EB0-9631-6149B01D32A3

Q30768542-7D095F61-F7D6-4EA6-BA7B-E3FDFB25E876

Q30768542-B846CA09-ECC5-4673-8356-F337D36809DE

P304

Q30768542-8ECFB502-089D-45B7-B9A2-3D3CFC6DCE1D

P31

Q30768542-A59A9507-C982-482C-AE07-91DE28F31EEF

P356

Q30768542-8F879EAE-1AA4-4599-9B81-128BE8C76036

P407

Q30768542-671F58F0-E6BF-48AC-AD0A-A575CA9F404C

P433

Q30768542-C7609642-F486-4219-9FA8-E150CA8870B3

P478

Q30768542-0DB9D715-3315-422F-8F50-DF3EA0761107

P577

Q30768542-074263BC-C497-41B0-89E1-D6848E1F860C

P698

Q30768542-8199198E-B7F4-4A19-905D-96646EA84466

P921

Q30768542-86561E12-C45C-4D1E-8230-0AA0C1CF0D2D

Q30768542-ECE9C0B3-5DDA-4A83-A113-5F891751CE88

P356

J.1600-0404.2003.02089.X

P1433

Acta Neurologica Scandinavica

P1476

Increased hepatocyte growth factor level in cerebrospinal fluid in Alzheimer's disease.

@en

P2093

Akatsu H

http://www.w3.org/2001/XMLSchema#string

Daikuhara Y

http://www.w3.org/2001/XMLSchema#string

Kakimoto K

http://www.w3.org/2001/XMLSchema#string

Nakajima M

http://www.w3.org/2001/XMLSchema#string

Ogawa K

http://www.w3.org/2001/XMLSchema#string

Ohnishi T

http://www.w3.org/2001/XMLSchema#string

Tsuboi Y

http://www.w3.org/2001/XMLSchema#string

Yamada T

http://www.w3.org/2001/XMLSchema#string

Yamamoto T

http://www.w3.org/2001/XMLSchema#string

P2860

Purification and cloning of hepatocyte growth factor activator inhibitor type 2, a Kunitz-type serine protease inhibitor

Hepatocyte growth factor activator inhibitor, a novel Kunitz-type serine protease inhibitor

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

White matter astrocytes produce hepatocyte growth factor activator inhibitor in human brain tissues

Pathophysiologic mechanisms in the development of age-related white matter changes of the brain.

Expression and functional interaction of hepatocyte growth factor-scatter factor and its receptor c-met in mammalian brain.

Somatostatin and octreotide for variceal bleeding.

Hepatocyte growth factor activator inhibitor type 2 lacking the first Kunitz-type serine proteinase inhibitor domain is a predominant product in mouse but not in human.

Emerging multipotent aspects of hepatocyte growth factor.

Immunohistochemistry with antibodies to hepatocyte growth factor and its receptor protein (c-MET) in human brain tissues.

P304

81-86

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1034/J.1600-0404.2003.02089.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P577

2003-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12580855

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

cerebrospinal fluid